RIVER EDGE, N.J.--(BUSINESS WIRE)--Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration (HDF) system for use with a hemodialysis machine for the treatment of patients with end stage renal disease, announced today financial results for the three and nine months ended September 30, 2015.
Help employers find you! Check out all the jobs and post your resume.
